Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

What's Going On With Tonix Pharmaceuticals Shares Today?

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading lower by 6.03% to $2.96 during Thursday’s pre-market session. The company announced Thursday that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq.

Tonix's shares had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days, which means Tonix's stock had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq.

Tonix on Monday, May 16 announced that it will implement a 1-for-32 reverse stock split of its outstanding common stock. This split became effective for trading purposes as of the commencement of trading on May 17.

See Also: Why C3.Ai Shares Are Getting Hammered Today

Tonix Pharmaceuticals is a clinical-stage biopharmaceutical company.

According to data from Benzinga Pro, Tonix Pharmaceuticals has a 52-week high of $45.44 and a 52-week low of $1.91.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.